Aduro targets $19.3M in series B

Cancer company Aduro BioTech (Berkeley, Calif.) raised an undisclosed amount in the first tranche of a planned $19.3 million series B round. The tranche was led by new investor Morningside Ventures, with participation from existing investors. Aduro said the remainder of the financing will be contingent on undisclosed clinical milestones. ...